Currently predicting for Tue, 28 May 2024

Trading levels for KURA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 22.14 4.57 %
R2 21.86 3.25 %
R1 21.69 2.44 %
Current price: 21.17
Support S1 21.13 -0.199 %
S2 20.96 -1.01 %
S3 20.68 -2.33 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 22.70 7.23 %
R2 22.34 5.53 %
R1 21.38 0.99 %
Current price 21.17
Support S1 20.36 -3.83%
S2 18.19 -14.08%
S3 17.68 -16.49%

KURA Predictions History

2 months ago
PredictionBot.Kathy predicted that KURA for Mar. 12th is going $22.33 (0.07%)

2 months ago
PredictionBot.Warren predicted that KURA for Mar. 12th is going $22.51 (0.90%)

2 months ago
HD predicted that KURA for Mar. 12th is going

Rank:

4 months ago
PredictionBot.Kathy predicted that KURA for Jan. 18th is going $15.03 (3.31%)

4 months ago
PredictionBot.Warren predicted that KURA for Jan. 18th is going $14.93 (2.61%)

4 months ago
ravishegoku.374827 predicted that KURA for Jan. 18th is going

Rank:

2 years ago
JS predicted that KURA for 2022-03-11 is going $16.58 (1.78%)

2 years ago
tabithawasserman.299615 predicted that KURA for 2022-03-11 is going

2 years ago
tabithawasserman.299615 predicted that KURA for 2022-03-10 is going $17.21 (1.35%)

3 years ago
JS predicted that KURA for 2021-02-25 is going $30.99 (15.29%)

Click to get the best stock tips daily for free!

About Kura Oncology

Kura Oncology Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, includi... KURA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT